You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 7,244,591


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,244,591
Title:Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone
Abstract: Novel Saccharomyces Cerevisiae mutant strains are provided for producing human parathyroid hormone. The novel strains acre genetically disrupted in at least one of the genes encoding the yapsin family of proteases Yapsin 1, Yapsin 2 and Yapsin 3 and harbor a human parathyroid hormone gene in their genomes. Culturing the novel strains results in the secretion of intact hPTH into culture media at high yield.
Inventor(s): Rhee; Sang Ki (Seoul, KR), Kana; Hyun Ah (Taejeon, KR), Chung; Bong Hyun (Taejeon, KR), Ko; Su Min (Kyunggi-do, KR)
Assignee: Dong Kook Pharmaceutical Co., Ltd. (Seoul, KR)
Application Number:10/363,329
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,244,591
Patent Claims:1. A method for producing a recombinant human parathyroid hormone (hPTH) from a Saccharomyces cerevisiae host, comprising the steps of: subjecting the Saccharomyces cerevisiae host to a deletion mutation in the genes encoding Yapsin 1 (YPS1) and Yapsin 3 (YPS3); transforming the Saccharomyces cerevisiae host with an expression vector containing a gene encoding human parathyroid hormone; and culturing the transformed Saccharomyces cerevisiae host in an appropriate medium.

2. The method as set forth in claim 1, wherein the deletion mutation is carried out by disrupting the genes encoding Yapsin 1 and Yapsin 3 by use of a Saccharomyces cerevisiae selection marker.

3. The method as set forth in claim 1, wherein the Saccharomyces cerevisiae host is further disrupted in the Yapsin 2 (YPS2) gene.

4. A Saccharomyces cerevisiae strain prepared by transforming a Saccharomyces cerevisiae yps1.DELTA.yps3.DELTA.mutant with an expression vector anchoring a human parathyroid hormone gene.

5. The Saccharomyces cerevisiae strain as set forth in claim 4, wherein the Saccharomyces cerevzsiae strain is Saccharomyces cerevisiae SLH16/pG10-hPTH (accession No. KCTC 0815BP) and the expression vector is pG10-hPTH1.

6. A Saccharomyces cerevisiae strain, prepared by transforming a Saccharomyces cerevisiae yps1.DELTA.yps2.DELTA.yps3A mutant with an expression vector anchoring a human parathyroid hormone gene.

7. The Saccharomyces cerevisiae strain as set forth in claim 6, wherein the Saccharomyces cerevisiae strain is Saccharomyces cerevisiae SLH18/pG10-hPTH (accession No. KCTC 0816BP) and the expression vector is pG10-hPTH1.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.